Home Top Stories Traditional medicine key to UHC in Africa, says endocrinologist

Traditional medicine key to UHC in Africa, says endocrinologist

0
59

 

L-R: Professor Martins Emeje, CEO/director general, Nigeria Natural Medicine Development Agency (NNMDA) and Professor Andrew E. Uloko, Department of Medicine, Faculty of Clinical Sciences, College of Health Sciences, Bayero University Kano, at the African Traditional Medicine Day programme.

Achieving Universal Health Coverage (UHC) across much of Africa, including Nigeria, may remain difficult without stronger collaboration between scientists and traditional medicine practitioners to standardise, validate and document traditional medicines, a professor of medicine and endocrinology at Bayero University Kano, Andrew Uloko, has said.

Prof. Uloko, of the Faculty of Clinical Sciences, College of Health Sciences, Bayero University Kano, said traditional medicine is already an important part of healthcare in Africa, with a substantial proportion of the population relying on it for their healthcare needs. However, he noted that its potential contribution to UHC remains largely underdeveloped.

He identified research and development as the bridge between traditional knowledge and evidence-based healthcare, stressing the need for government to invest in capacity building in pharmacognosy, toxicology and clinical research, while strengthening institutions responsible for traditional medicine development.

Speaking in an exclusive interview with Pharmanews shortly after his presentation at the commemoration of African Traditional Medicine Day 2026, organised by the Nigeria Natural Medicine Development Agency (NNMDA) in Lagos, the erudite endocrinologist said Africa cannot not fully harness the potential of natural medicine without stronger collaboration between physicians and traditional medicine practitioners.

He, however, stressed that such integration must be guided by scientific evidence, with safety, efficacy, quality and standardisation established before traditional medicines are incorporated more widely into mainstream healthcare.

“Well, if we say that traditional medicines are totally not useful, we may not be helping the situation because whether we like it or not, our population used traditional medicines several decades before the orthodox medicines came and they had results. We are not denying those results. I guess the main concern for practitioners, clinicians, is the fact that traditional medicines are used unregulated in a manner that there is no form of guidance,” he stated.

“The era of working in silos and living in denials is over,” he said. “We agree that we can complement each other, but what we preach is that the rigorous processes of refinement to be sure that those traditional medicines are safe, they are efficacious, and they are cost-effective, and they are affordable to our people are the main areas that I think will help.”

Uloko identified medicinal plants as rich sources of compounds that could be explored for therapeutic purposes, noting that, when properly studied and harnessed, they could offer useful therapeutic properties. He added that such plants provide structural diversity and are often culturally acceptable to the communities that used them.

He cited neem and other medicinal plants that had been used traditionally for generations, while noting that ginger and lemon also remained familiar traditional remedies for conditions such as colds and coughs.

Uloko further stressed the need to standardise traditional medicines, noting that while their traditional use could provide valuable knowledge, it did not by itself establish their safety or efficacy.

He said concerns among physicians centred on the safety and efficacy of traditional medicine products and the potential harm they could cause when used without adequate evidence or oversight.

According to him, “There is an opportunity for Africa to move from simply preserving its traditional medical heritage to transforming that knowledge into health innovation. To achieve this, several steps are necessary: documentation of traditional knowledge, scientific research, evidence generation, product development, regulation and improved access.”

He maintained that research serves as the bridge between traditional knowledge and modern healthcare, stressing that clinicians, researchers, traditional medicine practitioners and communities must work together rather than operate in isolation.

Also speaking on the theme of the celebration, “Reflection on Research and Development of Traditional Medicine Towards Achieving Universal Health Coverage”, the Director-General of NNMDA, Prof. Martins Emeje, underscored the importance of research and development in traditional medicine.

He said countries that fail to prioritise research and development of their natural resources for local medicines risk medicine insecurity.

Emeje also highlighted an important distinction between conventional medicine and natural medicine, noting that food could serve as a raw material or building block for medicines.

“Therefore, developing natural medicine can contribute to both food security and medicine security. However, this can only be achieved through sustained research and development.”

The NNMDA Director-General further highlighted differences between conventional research and development and research into natural medicines, noting that research does not necessarily have to take place entirely in laboratories.

“Research does not necessarily mean that everything must be taken to a laboratory. Different forms of research can be conducted within communities.”

He explained that researchers could engage traditional medicine practitioners, ask questions, gather information, document their practices and curate the knowledge they possess.

He therefore called for policies that would bring such knowledge into the formal research and healthcare system, noting that traditional medicine has a role to play in achieving UHC by contributing to access to quality, affordable and appropriate healthcare and medicines.

Emeje, however, cautioned against expecting Nigeria to achieve in a few years what countries such as China and India had developed over centuries. He said greater private-sector investment and sustained commitment would be necessary to advance Nigeria’s traditional medicine heritage.

“The private sector must become more interested in the development of traditional medicine. At present, there is limited private-sector investment because the returns are not immediate. In other parts of the world, individuals, families, foundations and private industries invest their resources and a percentage of their profits in natural-product research. When these products are eventually developed, countries such as Nigeria import them.”

He added that the ecosystem around traditional medicine has become more active over the past three years and that the momentum needed to be sustained over the next 25 years.

“Countries such as China and India have spent thousands of years developing their traditional medicine systems. We cannot expect to achieve the same level of development in three years.”

Also speaking at the event, the WHO Head of Traditional Medicine Unit, Dr Kim Sunchol, urged the Federal Government to invest in the proper documentation and regulation of traditional medicine as a means of harnessing the country’s natural heritage towards achieving UHC.

Acknowledging the place of herbal medicines in healthcare, Sunchol said traditional medicine is widely used across WHO member states, including Nigeria, with a significant proportion of the population relying on it.

He noted that the WHO Global Traditional Medicine Strategy 2025–2034 provides a framework for strengthening evidence, improving regulatory mechanisms and integrating safe and effective traditional medicine into national health systems where appropriate.

Sunchol, who joined the conference virtually, emphasised the role of government in providing clear policy guidance and establishing appropriate regulatory mechanisms for traditional medicine practitioners and products.

He called for the strengthening of national authorities and regulatory structures to ensure appropriate licensing and oversight of practitioners and products.

LEAVE A REPLY

Please enter your comment!
Please enter your name here